BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1211@pharmaconomics
DTSTAMP:20260707T034935Z
DTSTART;VALUE=DATE:20260130
DTEND;VALUE=DATE:20260131
SUMMARY:PHAR CRL — leniolisib
DESCRIPTION:An FDA complete response letter on leniolisib for APDS in children aged 4 to 11 years is in focus around Jan 30\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1828316/000182831626000008/a2025q4pressrelease.htm\n\nTrack it: https://www.pharmaconomics.com/e/1211
URL:https://www.pharmaconomics.com/e/1211
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:PHAR catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR